Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients (original) (raw)

• Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH (2001) Cytokines play an aetiopathogenic role in fibromialgia: a hypothesis and pilot study. Rheumatology 40:743–749
  Article PubMed CAS Google Scholar
• Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33:160–172
  Article PubMed CAS Google Scholar
• Carmona L, Ballina J, Gabriel R, Laffon A (2001) EPISER study group: the burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 60:1040–1045
  Article PubMed CAS Google Scholar
• Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson JF (1997) Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 24(3):555–559
  PubMed CAS Google Scholar
• Vargas-Alarcón G, Fragoso JM, Cruz-Robles D, Vargas A, Lao-Villadóniga JI, García-Fructuoso F, Ramos-Kuri M, Hernández F, Springall R, Bojalil R, Vallejo M, Martínez-Lavín M (2007) Catechol-O-methyltransferase (COMT) gene haplotypes in Mexican and Spaniard patients with fibromyalgia. Arthritis Res Ther 9:R110
  Article PubMed Google Scholar
• Senna ER, De Barros Al, Silva EO, Costa IF, Pereira LVB, Ciconelli RM, Ferraz MB (2004) Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 31:594–759
  PubMed Google Scholar
• Russell IJ (1998) Advances in fibromyalgia: possible role for central neurochemicals. Am J Med Sci 315:377–384
  Article PubMed CAS Google Scholar
• Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N (2003) Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 23:104–107
  PubMed Google Scholar
• Mannisto PT, Kaakkola S (1999) Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of new selective COMT inhibitors. Pharmacol Rev 51:593–628
  PubMed CAS Google Scholar
• Roussos P, Giakoumaki SG, Bitsios P (2009) Tolcapone effects on gating, working memory, and mood interact with the synonymous Catechol-O-methyltransferase rs4818C/G polymorphism. Biol Psychiatry 66:997–1004
  Article PubMed CAS Google Scholar
• García-Fructuoso FJ, Lao-Villadóniga JI, Beyer K, Santos C (2006) Relationship between catechol-O-methyltransferase genotypes and fibromyalgia’s severity. Reumatol Clin 2:168–172
  Article Google Scholar
• Nackley AG, Shabalina SA, Lambert JE, Conrad MS, Gibson DG et al (2009) Low enzymatic activity haplotypes of the human Catechol-O-methyltransferase gene: enrichment for marker SNPs. PLoS ONE 4(4):e5237
  Article PubMed Google Scholar
• Matsuda JB, Barbosa FR, Morel LJF, França SC, Zingaretti SM, Marins M, Da Silva LM, Pereira AMS, Fachin AL (2010) Serotonin receptor (5-HT2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: triggers of fibromyalgia? Braz J Rheumatol 50(2):141–149
  Google Scholar
• Bennett R (2005) The Fibromialgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23(Suppl.39):S154–S162
  PubMed CAS Google Scholar
• Nackley AG, Tan KS, Fecho K, Flood P, Maixner W (2005) COMT modulates pain sensitivity and cytokine production through both ß2 and ß3 adrenergic receptors. Washington, DC
• Nackley AG, Tan KS, Fecho K, Flood P, Diatchenko L, Maixner W (2007) Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain 128:199–208
  Article PubMed CAS Google Scholar
• Cohen H, Neumann L, Glazer Y, Ebstein RP, Buskila D (2009) The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia. Clin Exp Rheumatol 27(5 Suppl 56):S51–S56
  PubMed CAS Google Scholar
• White KP (1999) Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario. Arthritis Rheum 42:76–83
  Article PubMed CAS Google Scholar
• Martinez JE, Ferraz MB, Saio EI, Atra E (1994) Avaliação seqüencial do impacto de fibromialgia e artrite reumatóide na qualidade de vida. Braz J Reumatol 34:309–316
  Google Scholar
• Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu Y, Koeppe RA, Stohler CS, Goldman D (2003) COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240–1243
  Article PubMed CAS Google Scholar
• Shastry BS (2006) Pharmacogenetics and the concept of individualized medicine. Pharmacogenomics J 6:16–21
  Article PubMed CAS Google Scholar
• Evans WE, Relling MV (2004) Moving towards individualized medicine with pharmacogenomics. Nature 429:464–468
  Article PubMed CAS Google Scholar
• Weinshilboum R, Wang L (2004) Pharmacogenomics: bench to bedside. Nat Rev Drug Discov 3:739–748
  Article PubMed CAS Google Scholar
• Wilkinson GR (2005) Drug metabolism and variability among patients in drug response. N Engl J Med 352:2211–2221
  Article PubMed CAS Google Scholar
• Pinsonneault J, Sadee W (2003) Pharmacogenomics of multigenic diseases: sex-specific differences in disease and treatment outcome. AAPS PharmSci 5:E29
  Article PubMed Google Scholar
• Meyer UA (2004) Pharmacogenetics—five decades of therapeutic lessons from genetic diversity. Nat Rev Genet 5:669–676
  Article PubMed CAS Google Scholar
• Roses AD (2004) Pharmacogenetics and drug development: the path to safer and more effective drugs. Nat Rev Genet 5:645–656
  Article PubMed CAS Google Scholar
• Lesko LJ, Woodcock J (2004) Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective. Nat Rev Drug Discov 3:763–769
  Article PubMed CAS Google Scholar
• Efferth T, Volm M (2005) Pharmacogenetics for individualized cancer chemotherapy. Pharmacol Ther 9:9
  Google Scholar
• Goldstein DB, Tate SK, Sisodiya SM (2003) Pharmacogenetics goes genomic. Nat Rev Genet 4:937–947
  Article PubMed CAS Google Scholar
• Sadée W, Dai Z (2005) Pharmacogenetics/genomics and personalized medicine. Hum Mol Genet 14:207–214
  Article Google Scholar
• Rakvåg TT, Ross JR, Sato H, Skorpen F, Kaasa S, Klepstad P (2008) Genetic variation in the Catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain. Mol Pain 4:64. doi:10.1186/1744-8069-4-64
  PubMed Google Scholar
• Rakvag TT, Klepstad P, Baar C, Kvam TM, Dale O, Kaasa S, Krokan HE, Skorpen F (2005) The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain 116:73–78
  Article PubMed CAS Google Scholar